Published in Expert Opin Drug Discov on June 14, 2014
Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease. Wiley Interdiscip Rev Dev Biol (2016) 0.76
Building dialogues between clinical and biomedical research through cross-species collaborations. Semin Cell Dev Biol (2017) 0.75
Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell (1987) 20.27
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature (2007) 7.55
PTC124 targets genetic disorders caused by nonsense mutations. Nature (2007) 6.67
In vivo drug discovery in the zebrafish. Nat Rev Drug Discov (2005) 6.56
Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature (1986) 6.45
Collagen VI related muscle disorders. J Med Genet (2005) 3.38
Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet (2003) 3.15
Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development (1996) 3.15
ZFIN: enhancements and updates to the Zebrafish Model Organism Database. Nucleic Acids Res (2010) 3.02
Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve (2006) 2.98
Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum Mutat (2009) 2.67
Time course of the development of motor behaviors in the zebrafish embryo. J Neurobiol (1998) 2.55
Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum Mol Genet (1998) 2.30
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med (2006) 2.25
Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet (2009) 2.23
DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature (2011) 2.23
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther (2011) 2.06
Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu Rev Physiol (2009) 2.03
Hooked! Modeling human disease in zebrafish. J Clin Invest (2012) 2.00
A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays. PLoS Biol (2013) 1.98
Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo. Development (2003) 1.95
Centronuclear myopathies: a widening concept. Neuromuscul Disord (2010) 1.88
Distinct and dynamic myogenic populations in the vertebrate embryo. Curr Opin Genet Dev (2009) 1.78
Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci U S A (2007) 1.74
Congenital myopathies: an update. Curr Neurol Neurosci Rep (2012) 1.66
Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos. Development (2002) 1.66
Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124. Proc Natl Acad Sci U S A (2010) 1.64
The development and behavioral characteristics of the startle response in the zebra fish. Dev Psychobiol (1974) 1.61
Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy. PLoS One (2007) 1.60
A model 450 million years in the making: zebrafish and vertebrate immunity. Dis Model Mech (2012) 1.59
The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy. Proc Natl Acad Sci U S A (2007) 1.56
NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy. PLoS Biol (2012) 1.53
Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A (2010) 1.48
The dystrophin associated protein complex in zebrafish. Hum Mol Genet (2003) 1.48
Drug screening in a zebrafish model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A (2011) 1.48
Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease. Development (2007) 1.46
The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol (2013) 1.45
Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo. Nat Neurosci (2002) 1.44
Macrophage plasticity and the role of inflammation in skeletal muscle repair. Mediators Inflamm (2013) 1.40
Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. Am J Pathol (2003) 1.33
The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies. Hum Mol Genet (2011) 1.30
In vivo imaging of molecular interactions at damaged sarcolemma. Dev Cell (2012) 1.30
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies. Mamm Genome (2012) 1.28
Flightless flies: Drosophila models of neuromuscular disease. Ann N Y Acad Sci (2010) 1.28
Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy. J Pathol (2012) 1.26
Splice modulating therapies for human disease. Cell (2012) 1.26
Pharmacological rescue of the dystrophin-glycoprotein complex in Duchenne and Becker skeletal muscle explants by proteasome inhibitor treatment. Am J Physiol Cell Physiol (2005) 1.26
Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy. Hum Mutat (2012) 1.25
Ataluren as an agent for therapeutic nonsense suppression. Annu Rev Med (2012) 1.24
accordion, a zebrafish behavioral mutant, has a muscle relaxation defect due to a mutation in the ATPase Ca2+ pump SERCA1. Development (2004) 1.23
Zebrafish models of collagen VI-related myopathies. Hum Mol Genet (2010) 1.21
Lying low but ready for action: the quiescent muscle satellite cell. FEBS J (2013) 1.17
Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol Med (2013) 1.16
High-throughput target-selected gene inactivation in zebrafish. Methods Cell Biol (2011) 1.15
Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy. Brain (2012) 1.14
Gene and cell-mediated therapies for muscular dystrophy. Muscle Nerve (2013) 1.14
The CRISPR system--keeping zebrafish gene targeting fresh. Zebrafish (2013) 1.13
What Can We Learn From Clinical Trials of Exon Skipping for DMD? Mol Ther Nucleic Acids (2014) 1.13
The use of zebrafish mutants to identify secondary target effects of acetylcholine esterase inhibitors. Toxicol Sci (2003) 1.11
Zebrafish orthologs of human muscular dystrophy genes. BMC Genomics (2007) 1.10
Pathfinding and synapse formation in a zebrafish mutant lacking functional acetylcholine receptors. Neuron (1990) 1.09
Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology. Neuromuscul Disord (2010) 1.08
Mutations affecting skeletal muscle myofibril structure in the zebrafish. Development (1990) 1.06
Analysis of Pax7 expressing myogenic cells in zebrafish muscle development, injury, and models of disease. Dev Dyn (2011) 1.06
Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases. Mol Med (2011) 1.06
Quantification of birefringence readily measures the level of muscle damage in zebrafish. Biochem Biophys Res Commun (2012) 1.01
Time-lapse analysis and mathematical characterization elucidate novel mechanisms underlying muscle morphogenesis. PLoS Genet (2008) 1.01
Non-Ca2+-conducting Ca2+ channels in fish skeletal muscle excitation-contraction coupling. Proc Natl Acad Sci U S A (2010) 0.99
The 2014 version of the gene table of monogenic neuromuscular disorders (nuclear genome). Neuromuscul Disord (2013) 0.97
Swimming into prominence: the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies. FEBS J (2013) 0.97
Progress in therapy for Duchenne muscular dystrophy. Exp Physiol (2011) 0.96
Vertebrate myotome development. Birth Defects Res C Embryo Today (2005) 0.95
Mutation in the delta-subunit of the nAChR suppresses the muscle defects caused by lack of Dystrophin. Dev Dyn (2005) 0.95
Evaluation of exon-skipping strategies for Duchenne muscular dystrophy utilizing dystrophin-deficient zebrafish. J Cell Mol Med (2011) 0.93
Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila. Development (2012) 0.93
Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment. FASEB J (2013) 0.92
Laminin-211 in skeletal muscle function. Cell Adh Migr (2012) 0.92
Analysis of skeletal muscle defects in larval zebrafish by birefringence and touch-evoke escape response assays. J Vis Exp (2013) 0.92
Nrk2b-mediated NAD+ production regulates cell adhesion and is required for muscle morphogenesis in vivo: Nrk2b and NAD+ in muscle morphogenesis. Dev Biol (2010) 0.91
Genotype-phenotype correlations in recessive RYR1-related myopathies. Orphanet J Rare Dis (2013) 0.90
A mutation in serca underlies motility dysfunction in accordion zebrafish. Dev Biol (2004) 0.90
Control of muscle fibre-type diversity during embryonic development: the zebrafish paradigm. Mech Dev (2013) 0.89
The zebrafish ennui behavioral mutation disrupts acetylcholine receptor localization and motor axon stability. Dev Neurobiol (2008) 0.89
Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy. J Mol Med (Berl) (2013) 0.86
The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish. PLoS Curr (2011) 0.86
Zebrafish models flex their muscles to shed light on muscular dystrophies. Dis Model Mech (2012) 0.86
Dysferlin and animal models for dysferlinopathy. J Toxicol Pathol (2012) 0.86
The myopathy-causing mutation DNM2-S619L leads to defective tubulation in vitro and in developing zebrafish. Dis Model Mech (2013) 0.86
Muscle diseases in the zebrafish. Neuromuscul Disord (2012) 0.85
Pharmacological therapies for muscular dystrophies. Curr Opin Neurol (2012) 0.85
A myogenic precursor cell that could contribute to regeneration in zebrafish and its similarity to the satellite cell. FEBS J (2013) 0.85
Embryonic senescence and laminopathies in a progeroid zebrafish model. PLoS One (2011) 0.84
Animal models of muscular dystrophy. Prog Mol Biol Transl Sci (2012) 0.83
Novel excitation-contraction coupling related genes reveal aspects of muscle weakness beyond atrophy-new hopes for treatment of musculoskeletal diseases. Front Physiol (2014) 0.82
Analysis of embryonic and larval zebrafish skeletal myofibers from dissociated preparations. J Vis Exp (2013) 0.81
Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling. Hum Mol Genet (2013) 0.80
Genetically modified pigs to model human diseases. J Appl Genet (2014) 0.80
The spinning task: a new protocol to easily assess motor coordination and resistance in zebrafish. Zebrafish (2013) 0.79
The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy. PLoS Curr (2013) 0.79
Animal models in therapeutic drug discovery for oculopharyngeal muscular dystrophy. Drug Discov Today Technol (2013) 0.76